$GLUE
Monte Rosa Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is GLUE down today? It is at $14.77 (-6.34%), and our scanner flagged it 112 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GLUE spikes, and full due diligence on GLUE — key stats, earnings, dilution and insider activity. Free.
Get free $GLUE alerts the moment volume spikes
Our scanner flagged $GLUE 112 times in the last 30 days. Create a free account to track $GLUE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $14.77
- Change today
- -6.34%
- Previous close
- $15.77
- 52-week range
- $4.30 – $25.77
- Market cap
- $1.28B
- Total held
- 6.8%
- Tradeable float
- 79.5M 93% of shares · after 7% insiders + institutional n/a
- Short interest
- 16.5M ▼ -4% vs prior · as of 2026-07-31
- Short % of float
- 20.7%
- Days to cover
- 10.6d
- Avg daily volume
- 1.4M
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5m
- 0.7x
- 15m
- 0.4x
- 1h
- 0.8x
- 1D
- 0.2x
Get free GLUE + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $GLUE down today?
Here is the latest on GLUE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GLUE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystMonte Rosa Therapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filingSC 13G/APassive 5%+ stake updatedAug 14, 2026 · 5 days agoAnalyst data via Nasdaq. Not investment advice.
Insiders
1 buys, 17 sells last 3 months (7/33 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Warmuth Markus Officer | Sold (automatic/other) | -10K 0.01% of company | sold 1.6% | 585K | $220K at $23.18 | Jul 16, 26 |
Champoux Jennifer Officer | Sold (automatic/other) | -4K | sold 6.5% | 62K | $102K at $23.38 | Jul 15, 26 |
Champoux Jennifer Officer | Other | 4K | added 7.0% | 67K | $17K at $3.98 | Jul 15, 26 |
Townson Sharon Officer | Sold (automatic/other) | -6K | sold 8.1% | 68K | $140K at $23.25 | Jul 6, 26 |
Townson Sharon Officer | Other | 6K | added 8.8% | 74K | $37K at $6.14 | Jul 6, 26 |
Behbahani Ali Director | Acquired (grant/award) | +15K 0.02% of company | n/a | 15K | n/a | Jul 1, 26 |
Behbahani Ali Director | Sold (automatic/other) | -1.01M 1.2% of company | sold 13% | 6.69M | n/a | Jul 1, 26 |
Janku Filip Officer | Sold (automatic/other) | -5K | sold 8.2% | 61K | $132K at $24.50 | Jun 30, 26 |
Janku Filip Officer | Other | 5K | added 8.9% | 66K | $73K at $13.41 | Jun 30, 26 |
Manning Anthony M. Director | Sold (automatic/other) | -10K 0.01% of company | n/a | n/a | $231K at $23.11 | Jun 29, 26 |
Manning Anthony M. Director | Other | 10K 0.01% of company | n/a | 10K | $42K at $4.16 | Jun 29, 26 |
Janku Filip Officer | Sold (automatic/other) | -6K | sold 9.1% | 60K | $138K at $22.95 | Jun 29, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $GLUE runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 14,375,000 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · Priced at $23.9999/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$GLUE Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$GLUE Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to GLUE
Comparable names in biological products, (no diagnostic substances), closest in size first.
GLUE stock FAQ
Why is $GLUE down today?
Here is the latest on GLUE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GLUE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the GLUE stock price today?
GLUE last traded at $14.77, down 6.34% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live GLUE alerts?
The GLUE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GLUE 112 times in the last 30 days.
What exchange is GLUE on?
GLUE (Monte Rosa Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $1.28B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is GLUE good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GLUE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.